Nectar Lifescience Ltd Quarterly Results

Gross Sales

340.26

489.32

504.12

497.45

417.51

Excise Duty

59.6

60.41

49.79

69.56

58.66

Net Sales

280.67

428.91

454.33

427.88

358.85

Other Operating Income

0.01

1.79

0.65

0.21

0.45

Other Income

0.35

0.08

0.57

0.69

0.55

Total Income

281.02

430.77

455.56

428.79

359.85

Total Expenditure

342.56

585

410.27

384.76

319.5

PBIDT

-61.54

-154.23

45.28

44.02

40.35

Interest

18.7

17.67

17.12

19.81

19.98

PBDT

-80.24

-171.9

28.16

24.21

20.38

Depreciation

16.52

15.77

15.61

15.55

15.46

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

-33.52

-57.58

4.71

3.07

1.95

Reported Profit After Tax

-63.23

-130.09

7.84

5.6

2.97

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-63.23

-130.09

7.84

5.6

2.97

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-63.23

-130.09

7.84

5.6

2.97

EPS (Unit Curr.)

-2.82

-5.8

0.35

0.25

0.13

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.43

22.43

22.43

22.43

22.43

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-21.92

-35.95

9.96

10.28

11.24

PBDTM(%)

-28.58

-40.07

6.19

5.65

5.67

PATM(%)

-22.52

-30.33

1.72

1.3

0.82